98%
921
2 minutes
20
Aims: In this study, we aimed to investigate the protective effect of apilarnil on kidney damage in the sepsis model induced by LPS.
Main Methods: 64 Sprague Dawley adult male rats were randomly divided into eight groups; control group, groups in which 0.2, 0.4 and 0.8 g/kg/bw apilarnil (API) was applied by oral gavage method for 10 days, LPS group in which 30 mg/kg/bw lipopolysaccharide (LPS) administered as intraperitoneally, groups in which LPS + 0.2, LPS+ 0.4 and LPS +0,8 API was applied. Six hour after the last administration the rats were anesthetized for euthanasia and kidney tissues were removed for RT-PCR analysis, immunohistochemical analysis and histopathologic analysis.
Key Finding: According to the results of RT-PCR expression levels of IL-6, IL-1β, NF-κB, TNF-α and TLR4 were significantly reduced in the LPS + 0,8 API group. Immunoreactivity of TLR4, pNF-κB and TNF-α levels in the LPS + 0.8 apilarnil group were significantly lower than in the LPS and LPS + 0.2 apilarnil groups. Histologically, compared to the LPS group the glomerular damage score tended to decrease in the LPS + 0,4 API and LPS+ 0,8 API groups, while the tubulointerstitial injury score decreased especially in the LPS + 0,8 API group.
Significance: In the present study, 0,8 g/kg dose of apilarnil promoted potential renoprotective effects which were achieved, at least in part, by the modulation of important markers of the local immune response in the model of LPS-induced sepsis.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.lfs.2021.119875 | DOI Listing |
Mol Biotechnol
September 2025
ASRT (Applied Science, Research and Technology), Inc., Atlanta, GA, USA.
The production of aminoglycoside-modifying genes by P. aeruginosa is one of the key mechanisms by which resistance to aminoglycoside antibiotics is developed. The aim of the present work was to examine the prevalence of aac(6)-Ib, aac(6)-IIa, and aac(3)-IIa aminoglycoside-modifying genes in clinical samples.
View Article and Find Full Text PDFGeospat Health
July 2025
Centre for Tropical Medicine Brasília, University of Brasília.
This study aimed to compare different address geocoding services and their applicability to epidemiological surveillance using dengue as an example. We applied a cross-sectional, descriptive study based on case notifications in the Notifiable Diseases Information System (SINAN) for the Brazilian capital in 2014 that includes complete postal code (CEP) information identified in the National Address Database for Statistical Purposes (CNEFE), which is considered the 'gold standard' for accuracy analysis. For records without CEP, georeferencing was performed through linkage of the original database with four geocoding tools: Google Maps, CNEFE, OpenStreetMap (OSM) and ArcGIS.
View Article and Find Full Text PDFMaedica (Bucur)
June 2025
Department of Clinical Microbiology and Microbial Pathogenesis, University Hospital of Heraklion, 71500 Crete, Greece.
Turicella otitidis is a Gram-positive bacillus, commensal inhabitant of the external auditory canal. It is the causative agent of external otitis and otitis media. Extra-otic infections are rarely been identified especially in patients with comorbidities.
View Article and Find Full Text PDFInt J Environ Res Public Health
August 2025
Department of Water Resources Management, Ndata School of Climate and Earth Sciences, Malawi University of Science and Technology, Limbe P.O. Box 5196, Malawi.
The use of untreated livestock manure in urban agriculture sustains soil fertility but risks disseminating antimicrobial resistance (AMR) in resource-limited settings. This study characterized antibiotic-resistant bacteria (ARB) prevalence across manure-soil-vegetable pathways in Blantyre, Malawi. Using a cross-sectional design, we collected 35 samples (poultry/pig manure, farm/home soils, subsp.
View Article and Find Full Text PDFJ Aerosol Med Pulm Drug Deliv
August 2025
Jolyon Mitchell Inhaler Consulting Services Inc., London, Canada.
The "Miller" design of mixing inlet (MI) enables a cascade impactor to operate at a constant flow rate while the orally inhaled product-on-test is evaluated at varying flow rates by controlling the flow of air via its side-arm. As part of the European Pharmaceutical Aerosol Group (EPAG) Impactor subgroup, we report a cross-industry experimental investigation by five organizations to determine internal losses of different inhaler-generated aerosolized medications within commercially available MIs, focusing on pharmacopeial methods for product testing. Evaluations were undertaken of solution and suspension formulations delivered by pressurized metered dose inhalers (pMDIs), passive dry powder inhalers (DPIs), and compressed air-jet and vibrating mesh nebulizers.
View Article and Find Full Text PDF